Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders
Open Access
- 4 January 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 146, 112610
Abstract
No abstract availableKeywords
Funding Information
- Deanship of Scientific Research, King Saud University
- King Abdulaziz University (FP-81–42)
- Deanship of Scientific Research, King Faisal University
- King Khalid University (R.G.P1/227/41)
This publication has 305 references indexed in Scilit:
- Biosynthetic Pathway and Health Benefits of Fucoxanthin, an Algae-Specific Xanthophyll in Brown SeaweedsInternational Journal of Molecular Sciences, 2013
- Viruses and neurodegenerationVirology Journal, 2013
- Astaxanthin Suppresses MPP+-Induced Oxidative Damage in PC12 Cells through a Sp1/NR1 Signaling PathwayMarine Drugs, 2013
- Symptomatic atherosclerosis is associated with an altered gut metagenomeNature Communications, 2012
- Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitroFood and Chemical Toxicology, 2011
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Air pollution: mechanisms of neuroinflammation and CNS diseaseTrends in Neurosciences, 2009
- β-Carotene conversion products and their effects on adipose tissueGenes & Nutrition, 2009
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame ProjectThe American Journal of Medicine, 2006